Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: A systematic review and meta-Analysis

BMJ Open

Volumn 7, Issue 10, 2017, Pages

  Chen, Feng ^a   Duan, Guangyou ^a   Wu, Zhuoxi ^a   Zuo, Zhiyi ^b   Li, Hong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

anaesthesia; cardiac surgery; cardiopulmonary bypass.; cerebral protection

Indexed keywords

DESFLURANE; ISOFLURANE; SEVOFLURANE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; NEUROPROTECTIVE AGENT; OXYGEN;

CARDIOPULMONARY BYPASS; COCHRANE LIBRARY; EMBASE; HEART SURGERY; HUMAN; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; MEDLINE; META ANALYSIS; MINI MENTAL STATE EXAMINATION; NEUROPROTECTION; OUTCOME VARIABLE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VENOUS OXYGEN TENSION; WARMING; BLOOD; COGNITIVE DEFECT; COMPARATIVE STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD;

ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CARDIOPULMONARY BYPASS; COGNITIVE DYSFUNCTION; HUMANS; NEUROPROTECTIVE AGENTS; OXYGEN; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85031315952     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-014629     Document Type: Review

References (44)

1. Lamy A, Devereaux PJ, Prabhakaran D, et al. Effects of off-pump and on-pump coronary-Artery bypass grafting at 1 year. N Engl J Med 2013;368:1179-88.
2. Lamy A, Devereaux PJ, Prabhakaran D, et al. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting. N Engl J Med 2016;375:2359-68.
3. McKhann GM, Grega MA, Borowicz LM, et al. Stroke and encephalopathy after cardiac surgery: An update. Stroke 2006;37:562-71.
4. Hogue CW, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: An evidence-based appraisal of current practices. Anesth Analg 2006;103:21-37.
5. Wimmer-Greinecker G, Matheis G, Brieden M, et al. Neuropsychological changes after cardiopulmonary bypass for coronary artery bypass grafting. Thorac Cardiovasc Surg 1998;46:207-12.
6. Blumenthal JA, Mahanna EP, Madden DJ, et al. Methodological issues in the assessment of neuropsychologic function after cardiac surgery. Ann Thorac Surg 1995;59:1345-50.
7. Pape M, Engelhard K, Eberspher E, et al. The long-Term effect of sevoflurane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth Analg 2006;103:173-9.
8. Sakai H, Sheng H, Yates RB, et al. Isoflurane provides long-Term protection against focal cerebral ischemia in the rat. Anesthesiology 2007;106:92-9.
9. Selman WR, Spetzler RF, Roessmann UR, et al. Barbiturate-induced coma therapy for focal cerebral ischemia. Effect after temporary and permanent MCA occlusion. J Neurosurg 1981;55:220-6.
10. Iwata T, Inoue S, Kawaguchi M, et al. Comparison of the effects of sevoflurane and propofol on cooling and rewarming during deliberate mild hypothermia for neurosurgery. Br J Anaesth 2003;90:32-8.
11. Dabrowski W, Rzecki Z, Czajkowski M, et al. Volatile anesthetics reduce biochemical markers of brain injury and brain magnesium disorders in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2012;26:395-402.
12. Sagara Y, Hendler S, Khoh-Reiter S, et al. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 1999;73:2524-30.
13. Wang H, Lu S, Yu Q, et al. Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects. Front Biosci 2011;3:604-15.
14. McAuliffe JJ, Loepke AW, Miles L, et al. Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology 2009;111:533-46.
15. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
16. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
17. Min J, Yanlin B. Target controlled infusion of propofol in shallow perioperative cardiopulmonary bypass for brain protection. Int J Clin Exp Med 2007;4:120-1.
18. Huaping Y. Two methods of anesthesia of CPB heart valve replacement patients plasma level and the influence of cognitive function according to beta. Shandong Med 2015;55:71-2.
19. Lei L, Weifu L, Jianchun F, et al. Effects of different anesthesia on cognition function in geriatric patients following off-pump coronary artery bypass grafting. Chin J Geriatr Heart Brain Vessel Dis 2010;12:1002-4.
20. Newman MF, Croughwell ND, White WD, et al. Pharmacologic electroencephalographic suppression during cardiopulmonary bypass: A comparison of thiopental and isoflurane. Anesth Analg 1998;86:246-51.
21. Woodcock TE, Murkin JM, Farrar JK, et al. Pharmacologic EEG suppression during cardiopulmonary bypass: cerebral hemodynamic and metabolic effects of thiopental or isoflurane during hypothermia and normothermia. Anesthesiology 1987;67:218-24.
22. Gnver S, Aydinli B, et al. The effect of sevoflurane vs. TIVA on cerebral oxygen saturation during cardiopulmonary bypassrandomized trial. Adv Clin Exp Med 2014;23:919-24.
23. Tingting C, Gang W, Qi Z, et al. The comparison between isoflurane and propofol with effect on cerebral protection in cardiac valve replacement Surgery. Chin J ECC 2007;5:91-93-117.
24. Jianrong G, Donglin J, Liyuan R, et al. Isoflurane and propofol for extracorporeal circulation open-heart surgery in patients with a comparative study of perioperative cerebral protection. Chin J Clin Pharmacol Ther 2009;14:812-7.
25. Shudong M. Propofol and seven halothane Anesthesia for experacorporeal circulation of brain protection effect comparison. Chin & F Med treatment 2015;12:145-6.
26. Singh SP, Kapoor PM, Chowdhury U, et al. Comparison of S100â levels, and their correlation with hemodynamic indices in patients undergoing coronary artery bypass grafting with three different anesthetic techniques. Ann Card Anaesth 2011;14:197-202.
27. Kanbak M, Saricaoglu F, Avci A, et al. Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: A preliminary study of S-100beta protein levels. Can J Anaesth 2004;51:712-7.
28. Baki ED, Aldemir M, Kokulu S, et al. Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and s100â protein during coronary artery bypass grafting. Inflammation 2013;36:1327-33.
29. Jiying Z, Feng X, Xianjie W, et al. Brain protection of desflurane in old patients undergoing coronary artery bypass grafting. Chin J New Drugs Clin Rem 2010;29:847-9.
30. Wang DD, Bordey A. The astrocyte odyssey. Prog Neurobiol 2008;86:342-67.
31. An SA, Kim J, Kim OJ, et al. Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke. Clin Biochem 2013;46:710-5.
32. Kuzumi E, Vuylsteke A, Guo X, et al. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 2000;85:936-7.
33. Rasmussen LS, Christiansen M, Eliasen K, et al. Biochemical markers for brain damage after cardiac surgery-Time profile and correlation with cognitive dysfunction. Acta Anaesthesiol Scand 2002;46:547-51.
34. Svenmarker S, Engstr KG, Karlsson T, et al. Influence of pericardial suction blood retransfusion on memory function and release of protein S100B. Perfusion 2004;19:337-43.
35. Goldman S, Sutter F, Ferdinand F, et al. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum 2004;7:E376-E381.
36. McMurtrey RJ, Zuo Z. Isoflurane preconditioning and postconditioning in rat hippocampal neurons. Brain Res 2010;1358:184-90.
37. Lee JJ, Li L, Jung HH, et al. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008;108:1055-62.
38. Julier K, da Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A doubleblinded, placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27.
39. Kim M, Kim M, Kim N, et al. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. Am J Physiol Renal Physiol 2007;293:F1827-F1835.
40. Lee HT, Kim M, Kim J, et al. TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis. Am J Nephrol 2007;27:416-24.
41. Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008;248:909-18.
42. Li H, Yin J, Li L, et al. Isoflurane postconditioning reduces ischemiainduced nuclear factor-êB activation and interleukin 1â production to provide neuroprotection in rats and mice. Neurobiol Dis 2013;54-216-24.
43. Zuo Z. A novel mechanism for sevoflurane preconditioning-induced neuroprotection. Anesthesiology 2012;117:942-4.
44. Uhlig C, Bluth T, Schwarz K, et al. Effects of Volatile Anesthetics on Mortality and Postoperative Pulmonary and Other Complications in Patients Undergoing Surgery: A Systematic Review and Metaanalysis. Anesthesiology 2016;124:1230-45.